This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Companies Put Billions into Promo 'Freebies'

All those drug-branded pens and calendars have become something of a hot-button political issue.

Last month, the Massachusetts House of Representatives voted to repeal the state's 2008 gift ban, which regulates interactions between physicians and the pharmaceutical industry.

The American Medical Student Association is among the vocal supporters of the ban and, as part of its PharmFree campaign has advocated "the elimination of all pharmaceutical marketing gifts including meals, coffee mugs, pens and anything else that unnecessarily increases the cost of health care."

Though the future of the Bay State ban on "gifts" remains undecided, pharmaceutical companies have tried to head off other restrictions with voluntary ban. In 2008, member companies of the Pharmaceutical Research and Manufacturers of America established voluntary, self-policed guidelines that prohibit sales reps from providing most of these items. Among those member companies were Abbott (ABT), Bristol-Myers Squibb (BMY), Eli Lilly (LLY), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS) and Pfizer (PFE).

"When the pharmaceutical company guidelines went into place, between $700 million and $1 billion in sales went away," Andrews says. "I think they were offering that as a way to avoid more, potentially restrictive legislation. We are now seeing some cracks in that. Some companies are not necessarily following it, because there is no law that says they have to, but more importantly our distributors and suppliers have been creating products that do fit within the guidelines."

"Those guidelines, though restrictive, do allow items that are educational in nature or informative in nature," he adds. "So things like patient kits, digital photo frames, anatomical charts, these are some of the many kinds of unique promotional products that can still be given for a physician to either give to his patients or use in their office. The stringent guidelines have certainly reduced ink pens and some of the more casual kinds of things. But it actually brings everything up another level. Having the ability to be educational or informative has created an opportunity for us."

Nevertheless, Andrews says his organization is "trying to convince lawmakers that promotional products are advertising, not gifts."

"If I give you a mug with your name on it, is that really going to change what prescription you write for somebody? It puts the drug's name and proper spelling out there, with maybe some drug interaction stats and educational material for you to be informed as a physician," he says. "That is important. But these truly are not gifts and shouldn't be judged as such. These items are a lot different than a two-week vacation in Tahiti."

-- Written by Joe Mont in Boston.



>To contact the writer of this article, click here: Joe Mont.

>To follow the writer on Twitter, go to http://twitter.com/josephmont.

>To submit a news tip, send an email to: tips@thestreet.com.

RELATED STORIES:



Get more stock ideas and investing advice on our sister site, Stockpickr.com.

3 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,915.07 -70.54 -0.42%
S&P 500 1,964.68 -8.15 -0.41%
NASDAQ 4,396.2040 -22.83 -0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs